Heparin Market with COVID-19 Impact Analysis, By Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-low Molecular Weight Heparin (ULMWH)), By Source (Bovine, Porcine), By Application (Deep Vein Thrombosis (DVT), Atrial Fibrillation and Heart Attack, Coronery Artery Disease, Other Applications), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Heparin Market size was valued at USD 9,530 Million in 2022, expanding at a CAGR of 4.2 % from 2023 to 2030.
Heparin is a very effective anticoagulant agent that is commonly used in medicine to avoid blood clots. Heparin, which is either from animal tissues or synthesised synthetically, acts by blocking the action of blood clotting factors such as thrombin and factor Xa, lowering the risk of dangerous blood clot formation. It is frequently given via injection and is used in a variety of therapeutic situations, including operations, dialysis, and the treatment of deep vein thrombosis. Heparin\'s rapid onset and reversibility make it an important tool in the treatment of thrombotic diseases. However, precise dose and monitoring are required to avoid bleeding problems, making it a crucial component of current medical practise.
Heparin Market- Market Dynamics
- Heparin\'s efficacy in preventing and treating blood clots propel market demand
Heparin is a highly effective anticoagulant that works quickly to inhibit clotting factors, making it essential in situations where immediate clot prevention or dissolution is required, such as during surgeries, cardiac procedures, and the treatment of conditions such as deep vein thrombosis and pulmonary embolism. Heparin is a cornerstone drug for managing thrombotic disorders, improving the security of patients, and boosting outcomes in a variety of medical contexts due to its versatility across prophylactic and therapeutic settings, as well as its capacity to be quickly changed in case of bleeding complications.
Heparin Market- Key Insights
- As per the analysis shared by our research analyst, the global Heparin market is estimated to grow annually at a CAGR of around 4.2% over the forecast period (2023-2030)
- The Heparin industry is projected to grow at a significant rate due to Heparin\'s efficacy in preventing and treating blood clots
- Based on Type segmentation, Unfractionated Heparin (UFH) was predicted to show maximum market share in the year 2022
- Based on Source segmentation, Porcine was the leading type in 2022
- On the basis of region, Asia Pacific was the leading revenue generator in 2022
Heparin Market- Segmentation Analysis:
The Global Heparin Market is segmented on the basis of Type, Source, Application, and Region.
The market is divided into two categories based on Type: Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-low Molecular Weight Heparin (ULMWH). The Unfractionated Heparin (UFH) dominates the market. Pharmacological treatments for Tardive Dyskinesia (TD) are in great demand. Unfractionated Heparin (UFH) is in high demand due to its critical function as an anticoagulant in surgeries, cardiac interventions, and the treatment of thrombotic disorders, which ensures patient safety by avoiding or curing harmful blood clots.
The market is divided into two categories based on Source: Bovine, Porcine. The Porcine sector dominates the market and is likely to maintain its dominance during the forecast period. Porcine-derived Heparin is in high demand owing to its consistent supply from pig intestines. It is still necessary for the production of this critical anticoagulant medicine, which ensures a consistent supply for operations, dialysis, and clot-related medical treatments.
Heparin Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Heparin demand is high in the Asia-Pacific area and continues to rise owing to a variety of variables. The region\'s ageing population, as well as an increase in the frequency of cardiovascular illnesses, deep vein thrombosis, and other clot-related ailments, has increased the need for Heparin. In addition, an increase in surgical procedures, such as heart operations and joint replacements, needs the use of Heparin to avoid clot formation throughout and after surgery. As healthcare infrastructure develops in Asia-Pacific nations, so does access to medical treatments, increasing the need for Heparin in hospitals and clinics. Local pharmaceutical manufacturing and imports are required to fulfil this demand and provide a consistent supply of this vital anticoagulant.
Heparin Market- Competitive Landscape:
The Heparin market\'s competitive environment is characterized by numerous prominent competitors dominating the industry. Due to their wide product portfolios and global reach, major pharmaceutical firms such as Pfizer, Sanofi, and Fresenius Kabi maintain considerable market share. They provide a variety of Heparin formulations to meet the needs of different medicinal applications. Furthermore, some generic medicine makers compete by offering less expensive alternatives. Regulatory conformity, quality control, and guaranteeing a consistent supply of raw materials derived from animals are all critical elements impacting competitiveness. Mergers, acquisitions, and collaborations also influence the landscape, enabling enterprises to increase their market presence and compete in the volatile Heparin market.
Recent Developments:
- In February 2022, Techdow USA a vertically integrated generic injectables firm, announced today the commercialization of its Heparin Sodium Injection, USP in the United States..
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEPARIN MARKET KEY PLAYERS
- Pfizer
- Sanofi
- Fresenius Kabi
- Aspen Pharmacare
- LEO Pharma
- Teva Pharmaceuticals
- Amphastar Pharmaceuticals
- Baxter International
- GlaxoSmithKline (GSK)
- Braun Melsungen AG
- Mylan
- Sandoz
- Leo Pharma
- Pfizer
- Hikma Pharmaceuticals
GLOBAL HEPARIN MARKET, BY TYPE
- Unfractionated Heparin
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMWH)
GLOBAL HEPARIN MARKET, BY SOURCE
- Bovine
- Porcine
GLOBAL HEPARIN MARKET, BY APPLICATION
- Deep Vein Thrombosis (DVT)
- Atrial Fibrillation and Heart Attack
- Coronery Artery Disease
- Other Applications
GLOBAL HEPARIN MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Heparin Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Heparin Market Snippet by Type
2.1.2. Heparin Market Snippet by Source
2.1.3. Heparin Market Snippet by Application
2.1.4. Heparin Market Snippet by Country
2.1.5. Heparin Market Snippet by Region
2.2. Competitive Insights
3. Heparin Key Market Trends
3.1. Heparin Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Heparin Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Heparin Market Opportunities
3.4. Heparin Market Future Trends
4. Heparin Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Heparin Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Heparin Market Landscape
6.1. Heparin Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Heparin Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
7.1.2. Unfractionated Heparin
7.1.3. Low Molecular Weight Heparin (LMWH)
7.1.4. Ultra-low Molecular Weight Heparin (ULMWH)
8. Heparin Market – By Source
8.1. Overview
8.1.1. Segment Share Analysis, By Source, 2022 & 2030 (%)
8.1.2. Bovine
8.1.3. Porcine
9. Heparin Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
9.1.2. Deep Vein Thrombosis (DVT)
9.1.3. Atrial Fibrillation and Heart Attack
9.1.4. Coronery Artery Disease
9.1.5. Other Applications
10. Heparin Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Heparin Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Heparin Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Heparin Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Heparin Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Heparin Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Heparin Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Pfizer
11.2.2. Sanofi
11.2.3. Fresenius Kabi
11.2.4. Aspen Pharmacare
11.2.5. LEO Pharma
11.2.6. Teva Pharmaceuticals
11.2.7. Amphastar Pharmaceuticals
11.2.8. Baxter International
11.2.9. GlaxoSmithKline (GSK)
11.2.10. B. Braun Melsungen AG
11.2.11. Mylan
11.2.12. Sandoz
11.2.13. Leo Pharma
11.2.14. Pfizer
11.2.15. Hikma Pharmaceuticals
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
